CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Subscribe to see CYduct Diagnostics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CYduct Diagnostics, Inc. is a medical - devices company headquartered in Westport, United States. It is publicly listed (CYDX) with a market capitalisation of $14.2M. Xcout tracks 5 named people at CYduct Diagnostics, Inc., including Dom L. Gatto (President, Chief Executive Officer, Secretary, Treasurer & Chairman).
A few of CYduct Diagnostics, Inc.'s closest competitors — see the full list of competitors and alternatives →
BiBB Instruments AB is a medical technology company that develops and manufactures EndoDrill®, a patented series of motorized endoscopic biopsy instruments designed to improve cancer diagnostics. The system uses an electric rotating needle technology to obtain high-quality core tissue samples during ultrasound-guided endoscopic procedures for various cancers, including gastrointestinal, lung, and urological malignancies.
Medcaptain Medical Technology Co., Ltd. manufactures integrated perioperative medical devices in China, Europe, Asia, the Middle East, Africa, North America, and South America. It offers life support products, such as infusion systems, medication delivery products, anesthesia machines and vaporizers, workstations, imaging equipment, and other life support products, including airway management, pulmonary function testing devices, deep vein thrombosis (DVT) preventive pumps, vein illuminators, monitors, and veterinary life support products; minimally invasive intervention products, such as an endoscopic product portfolio for the diagnosis and treatment of conditions relating to the digestive system, including the gastrointestinal (GI) and hepatobiliary tracts, and the urological system; and In Vitro diagnostics products, such as thromboelastography analyzers, blood grouping analyzers, chemiluminescent immunoassay (CLIA) testing analyzers and reagent kits, and molecular diagnostics equipment and testing kits. The company sells its products through a chain of distributors globally. Medcaptain Medical Technology Co., Ltd. was formerly known as Shenzhen Yusheng Medical Technology Co., Ltd. and changed its name to Medcaptain Medical Technology Co., Ltd. in July 2023. Medcaptain Medical Technology Co., Ltd. was incorporated in 2011 and is based in Shenzhen, China.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
URO-1, Inc. is a privately held medical device company established in 2017 and based in Greensboro, North Carolina. The company develops and manufactures surgical solutions and instruments for biopsy procedures, specifically focusing on prostate and soft tissue cancer diagnostics.
Medimaging Integrated Solution Inc. specializes in delivering advanced digital and mobile diagnostic technology. The company engineers and produces a variety of digital handheld diagnostic scopes, alongside their essential auxiliary equipment. A key product line is the Horus scope system, which encompasses optical coherence tomography (OCT) capabilities, integrated control units, specialized software, and a full suite of accessories. Beyond hardware, Medimaging leverages artificial intelligence for screening applications, notably in detecting diabetic retinopathy, managing wound care, and supporting general medical diagnosis. They also provide comprehensive endoscopy solutions, utilizing advanced micro camera modules to ensure superior visualization and facilitate patient-focused care. These high-performance micro camera modules are also available as standalone components. Established in 2010, Medimaging Integrated Solution Inc. maintains its headquarters in Hsinchu City, Taiwan.
Star Equity Holdings, Inc. operates as a diversified entity, providing healthcare solutions across the United States and globally. The company's business is structured into four primary segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. Within its diagnostic divisions, Star Equity offers imaging services mainly to cardiologists, internal medicine specialists, and family practitioners. It also supplies imaging systems, such as nuclear cardiac and general-purpose nuclear equipment, to medical offices and hospitals. Additionally, the company develops, sells, and maintains solid-state gamma cameras, providing comprehensive maintenance contract services for these devices. Its Construction segment is involved in manufacturing modular housing units, structural wall panels, permanent wood foundation systems, and various other engineered wood products, while also supplying building materials to general contractors. The Investments segment focuses on managing a portfolio of investments and holding real estate assets. Headquartered in Old Greenwich, Connecticut, Star Equity Holdings, Inc. was founded in 1985 and was formerly known as Digirad Corporation until its rebranding in December 2020.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.